Key Takeaways
- Oklo (OKLO) advanced 7.2% Monday, finishing at $53.85 with approximately 8.29 million shares changing hands
- Wall Street consensus sits at “Moderate Buy” with an $84.30 average price target, though UBS, Citi, and B. Riley recently lowered their forecasts
- The company’s Q4 earnings fell short of expectations, posting −$0.27 per share versus the anticipated −$0.17
- Corporate insiders offloaded more than 818,000 shares valued at approximately $50.9 million during the past three months, including a CFO transaction
- The company’s inaugural Aurora reactor facility is scheduled for Idaho deployment in 2027, with projected revenues hitting $36 million by 2028
Oklo (OKLO) posted a 7.2% gain Monday, settling at $53.85. Shares reached an intraday peak of $53.96, climbing from Friday’s $50.25 close. Approximately 8.29 million shares traded hands, representing about 17% less than the typical daily volume of 10 million.
The upward movement occurs as nuclear power equities maintain investor attention, fueled by escalating electricity requirements from data center operations and artificial intelligence computing infrastructure.
Oklo’s valuation currently stands at approximately $9.35 billion. The stock trades below its 50-day moving average of $60.16 and significantly beneath its 200-day moving average of $89.90.
Wall Street Lowers Price Expectations
Analyst sentiment toward Oklo has moderated somewhat in recent sessions. UBS reduced its price objective from $95 down to $60 while maintaining a “neutral” stance. Citi lowered its forecast from $95 to $73.50, likewise assigning a “neutral” rating. B. Riley decreased its target from $129 to $92 while preserving a “buy” recommendation.
Cantor Fitzgerald maintained its position with an “overweight” designation and $122 price objective. Wedbush similarly retained its “outperform” assessment.
Collectively, analyst consensus registers as “Moderate Buy” with an $84.30 average price target. While this remains substantially above current trading levels, target prices have trended downward.
Among 19 analysts tracking the stock, two assign it a Strong Buy, nine recommend Buy, six suggest Hold, and two advise Sell.
Regarding financial performance, Oklo delivered a quarterly loss of $0.27 per share, falling short of the −$0.17 consensus estimate by $0.10. Full-year projections indicate an EPS of −$8.20 for the current fiscal period.
Significant Insider Transactions
Insider selling activity has intensified recently. CFO Richard Craig Bealmear divested 16,342 shares on April 1st at $51.08 per share, generating approximately $834,749. This transaction decreased his holdings by roughly 4%.
Insider William Carroll Murphy Goodwin likewise sold 2,820 shares during March at $56.69 each, reducing his position by nearly 15%.
Cumulatively, company insiders disposed of 818,766 shares valued at roughly $50.9 million throughout the last quarter. Despite these sales, insiders maintain 18.9% ownership, while institutional investors control 85.03%.
Oklo’s Aurora microreactor produces 1.5 MW independently and can expand to 75 MW per installation. The technology targets isolated and off-grid sites, utilizing metallic uranium fuel designed to operate approximately ten years without requiring refueling.
The enterprise currently generates negligible revenue. Management anticipates deploying its initial 75 MW Aurora Powerhouse reactor in Idaho during 2027. The company also secured a U.S. Department of Defense agreement to construct a reactor at Alaska’s Eielson Air Force Base.
Revenue projections indicate growth from less than $1 million in 2026 to $36 million by 2028.
